Target intelligence / Profile preview

Galactosidase, beta 1-like pseudogene

Molecular classification: Other (pseudogene)

Overview

The galactosidase, beta 1-like pseudogene (ENSG00000276391) is annotated as a pseudogene related to the GLB1L family. Pseudogenes are genomic sequences similar to known genes but are generally non-coding and do not produce functional proteins. This particular pseudogene should not be confused with the protein-coding genes *GLB1L* (galactosidase, beta 1-like)[2] or *GLB1* (galactosidase, beta 1), which encode active glycosyl hydrolase enzymes involved in lysosomal function and are implicated in human metabolic disorders. The pseudogene itself does not have a known biological function or involvement in disease, is not a therapeutic target, and is not considered relevant for clinical biomarker or drug development[5].

Other names: galactosidase, beta 1-like pseudogeneGLB1L pseudogene

Beyond the preview

Go deeper on Galactosidase, beta 1-like pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galactosidase, beta 1-like pseudogene.

Explore the full profile